高级搜索
影响上皮性卵巢癌复发患者预后相关临床病理因素分析[J]. 肿瘤防治研究, 2012, 39(10): 1228-1232. DOI: 10.3971/j.issn.1000-8578.2012.10.016
引用本文: 影响上皮性卵巢癌复发患者预后相关临床病理因素分析[J]. 肿瘤防治研究, 2012, 39(10): 1228-1232. DOI: 10.3971/j.issn.1000-8578.2012.10.016
Analysis of Clinical and Pathological Prognostic Factors for Recurrent Epithelial Ovarian Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(10): 1228-1232. DOI: 10.3971/j.issn.1000-8578.2012.10.016
Citation: Analysis of Clinical and Pathological Prognostic Factors for Recurrent Epithelial Ovarian Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(10): 1228-1232. DOI: 10.3971/j.issn.1000-8578.2012.10.016

影响上皮性卵巢癌复发患者预后相关临床病理因素分析

Analysis of Clinical and Pathological Prognostic Factors for Recurrent Epithelial Ovarian Cancer

  • 摘要: 目的 分析影响上皮性卵巢癌(epithelial ovarian cancer,EOC)复发患者预后的相关临床病理因素。方法 采用Kaplan-meier生存率曲线,Log rank检验和Cox模型多因素回归分析法对92例临床病理及随访资料完整的复发癌患者进行影响其预后的相关因素分析。结果 (1)92例复发上皮性卵巢癌临床病例的总体中位生存时间是18月(95%CI:16.052~19.948);(2) Kaplan-Meier单因素分析提示,FIGO 分期、复发距离末次化疗时间、复发部位、最大复发病灶、复发后伴有腹水、CA125升高、复发后二次肿瘤细胞减灭术、再次治疗化疗方案是影响复发EOC患者的重要预后因素(P<0.1)。而年龄、肿瘤细胞分级、初次治疗方案与预后无关(P>0.1);(3)Cox回归分析结果显独示,复发后再次治疗化疗方案、最大复发病灶大小、复发部位是影响患者预后的独立危险因素。结论 多个临床病理因素影响复发上皮性卵巢癌预后,其中复发后再次治疗化疗方案、最大复发病灶大小、复发部位是影响患者预后的独立危险因素。

     

    Abstract: Objective To analyze the clinical and pathological prognostic factors of recurrent epithelial ovarian cancer. Methods Kaplan-meier survival curves,Log-rank test and Cox multivariate test regression were used to analyze clinical and pathological prognostic factors of relapse epithelial ovarian cancer in 92 cases with recurrent epithelial ovarian cancer which clinical pathology and follow-up data was completed. Results (1) Ninety-two patients with recurrent epithelial ovarian carcinoma cases overall median survival time was 18 months (95%CI:16.065~19.948).(2) Kaplan-Meier univariate analysis showed that FIGO stage,recurrence time from the last chemotherapy,recurrence site,the largest recurrence lesion,relapse with ascites,CA125 increased,secondary cytoreductive surgery,chemotherapy program for recurrence was the impact of important prognostic factor for re-treatment patients with recurrent EOC(P<0.1).But there was no relationship between age,grade of tumor cell,initial treatment plan and prognosis(P>0.1).(3)The Cox regression analysis showed that re-treatment regimen after relapse,the maximum recurrence of tumor size,recurrence site was an independent prognostic risk factor. Conclusion There are multiple clinical and pathological factors for affecting prognosis of recurrence epithelial ovarian cancer.Re-treatment regimen after relapsed,the maximum recurrence of tumor size,recurrence site are independent prognostic risk factors.

     

/

返回文章
返回